Veterinary Medicines

PRIMUN NEWCASTLE HB1 Lyophilisate for suspension for chickens

Authorised
  • Newcastle disease virus, strain B1 Hitchner, Live
Download as PDF

Product identification

Medicine name:
PRIMUN NEWCASTLE HB1 Lyophilisate for suspension for chickens
PRIMUN NEWCASTLE HB1 Liofilizado para suspensão para galinhas
Active substance:
  • Newcastle disease virus, strain B1 Hitchner, Live
Target species:
  • Chicken
Route of administration:
  • Oculonasal use

Product details

Active substance and strength:
  • Newcastle disease virus, strain B1 Hitchner, Live
    6.00
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for suspension for injection
Withdrawal period by route of administration:
  • Oculonasal use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:
  • (ID2): 1 Box with 10 Bottle (Glass) with 1000 Dose (10000 Dose)
  • (ID1): 1 Box with 1 Bottle (-) with 1000 Dose (1000 Dose)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Calier Portugal Medicamentos E Produtos Veterinarios S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Calier S.A.
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 945/01/17DIVPT
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0272/001
Concerned member states:
  • Italy
  • Poland
  • Portugal
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 7/07/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."